603367 辰欣药业
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.3838.7169.4286.7386.781
总资产报酬率 ROA (%)1.8956.8357.3675.3115.334
投入资产回报率 ROIC (%)2.2728.2228.8786.3996.331

边际利润分析
销售毛利率 (%)59.71356.57358.78855.99555.463
营业利润率 (%)17.42614.36713.2808.9668.841
息税前利润/营业总收入 (%)16.77013.64512.5988.3208.646
净利润/营业总收入 (%)15.71512.93311.7758.6648.827

收益指标分析
经营活动净收益/利润总额(%)111.57786.51199.96895.16173.120
价值变动净收益/利润总额(%)20.60412.6505.6634.24919.761
营业外收支净额/利润总额(%)-0.2110.6470.5500.4390.509

偿债能力分析
流动比率 (X)3.5403.3333.6283.7013.400
速动比率 (X)2.9832.7883.1113.2492.912
资产负债率 (%)19.23320.74321.41521.41220.556
带息债务/全部投入资本 (%)2.7394.4584.5674.5272.434
股东权益/带息债务 (%)3,512.6842,118.0932,063.5452,078.6953,938.352
股东权益/负债合计 (%)417.263379.711364.479365.406386.412
利息保障倍数 (X)-27.061-16.725-16.697-12.136-36.002

营运能力分析
应收账款周转天数 (天)67.73161.93258.75854.20147.925
存货周转天数 (天)191.813158.092126.130118.211124.666